When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMF - Fervent Pharma completes mid-stage study for vasomotor symptoms candidate FP-101
Astellas Pharma Inc
Privately held Fervent Pharmaceuticals announces the completion of a Phase 2a clinical trial evaluating lead candidate FP-101 for the treatment of vasomotor symptoms (e.g., hot flashes, night sweats) associated with menopause.
More news on: Dare Bioscience, Inc., TherapeuticsMD, Astellas Pharma, Inc., Healthcare stocks news,